calendar
300 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 3,633 phase readout · 2,052 8k filing · 2,000 device pma
300 catalysts · 18,987 approval · 5,000 device 510k · 4,728 grant · 3,633 phase readout · 2,052 8k filing · 2,000 device pma
Anticipated earnings call for CSL LTD ($CSLLY).
Anticipated earnings call for Beyond Air, Inc. ($XAIR).
Anticipated earnings call for Haleon plc ($HLN).
Anticipated earnings call for SMITH & NEPHEW PLC ($SNN).
Anticipated earnings call for Scilex Holding Co ($SCLX).
Anticipated earnings call for BioXcel Therapeutics, Inc. ($BTAI).
Anticipated earnings call for ACME UNITED CORP ($ACU).
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Anticipated earnings call for Grifols SA ($GRFS).
Anticipated earnings call for Sanofi ($SNY).
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes
Therapy area: Oncology. Indication: Chronic Myelomonocytic Leukemia (CMML)
Therapy area: Dermatology. Indication: Androgenic Alopecia
Therapy area: Central Nervous System, Mouth and Dental Disorders. Indication: Post-Operative Pain, Unspecified Mouth and Dental Disorders
Therapy area: Central Nervous System. Indication: Epilepsy
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes
Therapy area: Central Nervous System, Gastrointestinal, Genito Urinary System, Respiratory. Indication: Anorexia Nervosa, Unspecified Gastrointestinal Disorders, Unspecified Genito Urinary Disorders, Unspecified Respiratory Disorders
Therapy area: Infectious Disease. Indication: Rabies
Therapy area: Cardiovascular. Indication: Unspecified Cardiovascular Disorders
Therapy area: Infectious Disease. Indication: Neisseria meningitidis Infections
Therapy area: Genito Urinary System, Infectious Disease. Indication: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), Unspecified Bacterial Infections
Therapy area: Hematological Disorders. Indication: Anemia, Iron Deficiency Anemia
Therapy area: Oncology. Indication: Nasopharyngeal Cancer
Anticipated earnings call for NOVARTIS AG ($NVS).
Anticipated earnings call for INCYTE CORP ($INCY).
Anticipated earnings call for ECOLAB INC. ($ECL).
Anticipated earnings call for Orion Group Holdings Inc ($ORN).
Therapy area: Central Nervous System, Musculoskeletal Disorders. Indication: Osteoarthritis, Post-Operative Pain
Therapy area: Genito Urinary System, Oncology. Indication: Bladder Cancer, Bladder Carcinoma, Kidney Cancer (Renal Cell Cancer), Metastatic Transitional (Urothelial) Tract Cancer, Renal Stones/Calculi, Transitional Cell Cancer (Urothelial Cell Cancer), Transitional Cell Carcinoma (Urothelial Cell Carcinoma), Ureter Cancer, Urethral Cancer
Anticipated earnings call for AbbVie Inc. ($ABBV).
Anticipated earnings call for ASTRAZENECA PLC ($AZN).
Anticipated earnings call for GSK plc ($GSK).
Anticipated earnings call for REGENERON PHARMACEUTICALS, INC. ($REGN).
Anticipated earnings call for TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA).
Anticipated earnings call for GLAUKOS Corp ($GKOS).
Anticipated earnings call for BIOGEN INC. ($BIIB).
Anticipated earnings call for Bausch & Lomb Corp ($BLCO).
Anticipated earnings call for SBA COMMUNICATIONS CORP ($SBAC).
Anticipated earnings call for AGIOS PHARMACEUTICALS, INC. ($AGIO).
Anticipated earnings call for IONIS PHARMACEUTICALS INC ($IONS).
Anticipated earnings call for Avantor, Inc. ($AVTR).
Anticipated earnings call for MERIT MEDICAL SYSTEMS INC ($MMSI).
Anticipated earnings call for Merck & Co., Inc. ($MRK).
Anticipated earnings call for CARDINAL HEALTH INC ($CAH).
Anticipated earnings call for DEXCOM INC ($DXCM).
Anticipated earnings call for ELI LILLY & Co ($LLY).
Anticipated earnings call for STRYKER CORP ($SYK).
Anticipated earnings call for BRISTOL MYERS SQUIBB CO ($BMY).
Anticipated earnings call for AMGEN INC ($AMGN).